Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 8/20 | 0.62 |
| ▸ | KCNJ11 | Q14654 | 8/20 | 0.62 |
| ▸ | ABCC8 | Q09428 | 6/20 | 0.62 |
| ▸ | KCNJ8 | Q15842 | 6/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6647586 | 1.00 | ABCC9 (0.62) | ABCC9KCNJ11ABCC8KCNJ8KMT2A | |
| SCHEMBL11168464 | 0.92 | ABCC9 (0.60) | ABCC9KCNJ11ABCC8KCNJ8KMT2A | |
| SCHEMBL11153498 | 0.91 | ABCC9 (0.58) | ABCC9KCNJ11ABCC8KCNJ8KMT2A | |
| SCHEMBL11152102 | 0.90 | ABCC9 (0.57) | ABCC9KCNJ11ABCC8KCNJ8KMT2A | |
| SCHEMBL9551254 | 0.89 | ABCC9 (0.55) | ABCC9KCNJ11ABCC8KCNJ8KMT2A | |
| SCHEMBL9463611 | 0.89 | ABCC9 (0.55) | ABCC9KCNJ11ABCC8KCNJ8KMT2A | |
| SCHEMBL11162938 | 0.88 | ABCC9 (0.55) | ABCC9KCNJ11ABCC8KCNJ8KMT2A | |
| SCHEMBL11166861 | 0.86 | ABCC9 (0.53) | ABCC9KCNJ11ABCC8KCNJ8KMT2A | |
| SCHEMBL11157789 | 0.85 | ABCC9 (0.51) | ABCC9KCNJ11ABCC8KCNJ8KMT2A | |
| SCHEMBL8774802 | 0.84 | ABCC9 (0.50) | ABCC9KCNJ11ABCC8KCNJ8KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040157755-A1 | Novel detergent compositions with enhanced depositing, conditioning and softness capabilities | JOHNSON & JOHNSON CONSUMER INC. | 2004-08-12 | — | — | US | claimed |
| US-20030176303-A1 | Novel detergent compositions with enhanced depositing, conditioning and softness capabilities | JOHNSON & JOHNSON CONSUMER INC. | 2003-09-18 | — | — | US | claimed |
| US-6419913-B1 | ENHANCING THE TRANSMEMBRANE PENETRATION OF BENEFIT AGENTS USING A CERTAIN NON-IONIC LIPID/SURFACTANT-CONTAINING FORMULATION; ESPECIALLY FOR TREATING ANDROGENETIC ALOPECIA WITH MINOXIDIL | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2002-07-16 | — | — | US | claimed |
| US-20020048558-A1 | Topical delivery systems for active agents | JOHNSON & JOHNSON CONSUMER INC. | 2002-04-25 | — | — | US | claimed |
| EP-1104280-A2 | TOPICAL DELIVERY SYSTEMS FOR ACTIVE AGENTS | Johnson & Johnson Consumer Companies, Inc. (US) | 2001-06-06 | — | — | EP | claimed |
| EP-1060732-A2 | Novel topical formulations comprising vesicle delivery systems | JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) | 2000-12-20 | — | — | EP | claimed |
| WO-2000007627-A2 | TOPICAL DELIVERY SYSTEMS FOR ACTIVE AGENTS | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2000-02-17 | — | — | WO | claimed |
| US-RE31244-E | Antihypertensive pyridylguanidine compounds | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) | 1983-05-17 | — | — | US | claimed |
| EP-1458337-B1 | STABLE SURFACTANT COMPOSITIONS FOR SUSPENDING COMPONENTS | SOLVAY USA INC (US) | 2016-05-04 | — | — | EP | disclosed |
| US-20140065088-A1 | COMBINED STABLE CATIONIC AND ANIONIC SURFACTANT COMPOSITIONS | RHODIA OPERATIONS (FR) | 2014-03-06 | — | — | US | disclosed |
| US-20130171088-A1 | COMBINED STABLE CATIONIC AND ANIONIC SURFACTANT COMPOSITIONS | RHODIA OPERATIONS (FR) | 2013-07-04 | — | — | US | disclosed |
| US-20130156712-A1 | STABLE SURFACTANT COMPOSITIONS FOR SUSPENDING COMPONENTS | RHODIA OPERATIONS (FR) | 2013-06-20 | — | — | US | disclosed |
| US-8394361-B1 | Stable surfactant compositions for suspending components | RHODIA OPERATIONS (FR) | 2013-03-12 | — | — | US | disclosed |
| US-20120213722-A1 | Combined Stable Cationic And Anionic Surfactant Compositions | RHODIA OPERATIONS (FR) | 2012-08-23 | — | — | US | disclosed |
| US-6284234-B1 | Topical delivery systems for active agents | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2001-09-04 | — | — | US | disclosed |
| EP-1104280-A2 | TOPICAL DELIVERY SYSTEMS FOR ACTIVE AGENTS | Johnson & Johnson Consumer Companies, Inc. (US) | 2001-06-06 | — | — | EP | disclosed |
| WO-2001036422-A1 | TRICYCLIC DIHYDROPYRIMIDINE POTASSIUM CHANNEL OPENERS | ABBOTT LABORATORIES (US) | 2001-05-25 | — | — | WO | disclosed |
| WO-2000007627-A2 | TOPICAL DELIVERY SYSTEMS FOR ACTIVE AGENTS | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2000-02-17 | — | — | WO | disclosed |
| US-5244664-A | Hair growth | LEO PHARMACEUTICAL PRODUCTS LTD. (DK) | 1993-09-14 | — | — | US | disclosed |
| US-RE31244-E | Antihypertensive pyridylguanidine compounds | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) | 1983-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030176303-A1 | Novel detergent compositions with enhanced depositing, conditioning and softness capabilities | CUTA, SGMS2, POLR1C | ABCC9 2023/4885KCNJ11 581/4885ABCC8 1023/4885 |
| US-20130171088-A1 | COMBINED STABLE CATIONIC AND ANIONIC SURFACTANT COMPOSITIONS | PHOSPHO1, PLA2G2C, SPTAN1 | ABCC9 1396/4885KCNJ11 1725/4885ABCC8 2516/4885 |
| US-20140065088-A1 | COMBINED STABLE CATIONIC AND ANIONIC SURFACTANT COMPOSITIONS | PHOSPHO1, PLA2G2C, SPTAN1 | ABCC9 1396/4885KCNJ11 1725/4885ABCC8 2516/4885 |
| US-20020048558-A1 | Topical delivery systems for active agents | SLC25A20, PLIN5, PLIN1 | ABCC9 1560/4885KCNJ11 1057/4885ABCC8 1224/4885 |
| US-20040157755-A1 | Novel detergent compositions with enhanced depositing, conditioning and softness capabilities | CUTA, SGMS2, POLR1C | ABCC9 2023/4885KCNJ11 581/4885ABCC8 1023/4885 |
| US-20130156712-A1 | STABLE SURFACTANT COMPOSITIONS FOR SUSPENDING COMPONENTS | PHOSPHO1, DEGS1, SPTAN1 | ABCC9 2240/4885KCNJ11 853/4885ABCC8 1374/4885 |
| US-20120213722-A1 | Combined Stable Cationic And Anionic Surfactant Compositions | PHOSPHO1, PLA2G2C, SPTAN1 | ABCC9 1396/4885KCNJ11 1725/4885ABCC8 2516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.